Christopher Adam
Directors
Board of Directors
Plasticell
Japan
Biography
Mr Adam has over 35 years of board level and operational experience in the pharmaceutical industry, including executive roles in the mergers of Glaxo with Wellcome, and in the acquisition of biotechs such as Affymax. He has sat on the executive committee of Glaxo Wellcome, the board of Glaxo Group Research, and at various times has served as President and CEO of Glaxo’s Japanese and French operations. Amongst other senior posts at Glaxo, he has held the positions of Director of Commercial Strategy, and Director of International Marketing. Mr Adam holds a BSc in Biochemistry from University College London, an EMBA from Stanford Business School and is a Chevalier de la Légion d’Honneur, commended for services to the healthcare industry.
Research Interest
Biochemistry, Pharmaceutical Science
